Breaking News
April 23, 2019 - Neuroscientists propose new theory about amyloid precursor protein connection in Alzheimer’s
April 23, 2019 - Mediterranean diet protects against overeating and obesity
April 23, 2019 - NUS scientists uncover novel biomarkers linked with ‘chemobrain’
April 23, 2019 - Novel ECCITE-seq technique expands multimodal single cell analysis
April 23, 2019 - Half of all American workplaces offer health and wellness programs
April 23, 2019 - Perinatal Complications Tied to Childhood Social Anxiety
April 23, 2019 - Research reveals how immune cells help tumors escape body’s defenses
April 23, 2019 - UAB receives $17 million grant to explore immune cells in inaccessible tissues of the human body
April 23, 2019 - Opening blocked arteries may be lifesaver for older heart attack patients
April 23, 2019 - Yposkesi chairman to speak on ‘Manufacturing and the CDMO Perspective’ at Cell and Gene Meeting
April 23, 2019 - Listeria Outbreak Linked to Deli Meats, Cheeses in 4 States
April 23, 2019 - Scientists find another way HIV can hide from vaccines
April 23, 2019 - EU ban on ‘meaty’ names for veggie food products would affect public sector
April 23, 2019 - KNAUER self-tests gender pay gap one month after Equal Pay Day
April 23, 2019 - Johns Hopkins study reports overdiagnosis of schizophrenia
April 23, 2019 - New approach to repair defects in fetal membranes could prevent life-long medical conditions
April 23, 2019 - Reviving the heart’s regenerative capacities using microRNAs
April 23, 2019 - New pediatric blood pressure guidelines can better predict kids at higher risk of heart disease
April 23, 2019 - Second HIV remission patient rekindles cure hope
April 23, 2019 - Sparse Treatment Options Complicate Cancer Care For Immigrants In South Texas
April 23, 2019 - Hole-forming protein could help control cancer growth
April 23, 2019 - Study examines factors associated with low use of hearing aids among older Hispanic/Latino adults
April 23, 2019 - Changes to Medicare rules could support care innovation for dialysis
April 23, 2019 - Cancer patients requiring emergency department care have better outcomes at original hospital
April 23, 2019 - Potential of liquid biopsy in cancer biomarker detection and prenatal testing
April 23, 2019 - Researchers identify circulating proteins associated with progression of diabetic kidney disease
April 23, 2019 - Microglia play vital role in regulating neuroinflammation, research shows
April 23, 2019 - Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis
April 23, 2019 - One-month regimen noninferior for preventing HIV-related TB
April 23, 2019 - Educational program for preschoolers successful in instilling heart healthy behaviors
April 23, 2019 - Asia’s diabetes epidemic increases risk of death among women, middle-aged people
April 23, 2019 - First-of-its-kind study highlights lethal impact of medical emergencies worldwide
April 23, 2019 - Workshop explores the future of artificial intelligence in medical imaging
April 23, 2019 - Research shows mindful body awareness training helps women recover from drug addiction
April 23, 2019 - Researchers are developing brand-new method to cure brain tumors
April 23, 2019 - Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP
April 23, 2019 - First case of person without the protein needed to transport vitamin D identified
April 23, 2019 - Precision-guided anticancer nanoparticles help enhance treatment of peritoneal tumors
April 23, 2019 - Smoking cessation during pregnancy associated with reduced risk of preterm birth
April 23, 2019 - Researchers discover why women get autoimmune diseases far more often than men
April 23, 2019 - New Medicare reimbursement rules provide some relief to safety-net hospitals
April 23, 2019 - Sensory Sensitivity Tied to Constipation in Young Children
April 23, 2019 - More than half of internal medicine graduates choosing primary care
April 22, 2019 - Researchers discover good news for fish populations living on bleached coral reefs
April 22, 2019 - Plant-based diets associated with lower risk of heart failure
April 22, 2019 - Food Allergies Can Strike at Any Age
April 22, 2019 - Cerebro-facio-thoracic dysplasia – Genetics Home Reference
April 22, 2019 - Poverty leaves a mark on our genes
April 22, 2019 - Countdown to Big Data in Precision Health: When industry and academia converge
April 22, 2019 - The U.S government may account for up to $37.8 billion due to opioid epidemic
April 22, 2019 - Improving ACA’s Insurance Coverage Provisions will lead to better care for patients
April 22, 2019 - Study identifies possible therapeutic effects of curcumin on stomach cancer
April 22, 2019 - Hyaline fibromatosis syndrome – Genetics Home Reference
April 22, 2019 - Scientists use CRISPR for possible ‘bubble boy’ therapy
April 22, 2019 - Hematologist (and a mom, singer, actress and much more) stands up for diversity
April 22, 2019 - Novel AI voice tool can help diagnose PTSD
April 22, 2019 - Physical activity may eliminate mortality risk caused by sedentary behavior
April 22, 2019 - Overlooked part of cell’s internal machinery may hold key to treating acute myeloid leukemia
April 22, 2019 - Nursing, medical, and dental students train together to improve pediatric oral health
April 22, 2019 - Soft bedding responsible for majority of sleep-related infant deaths, study reveals
April 22, 2019 - Study finds worse health-related quality of life among transgender adults
April 22, 2019 - MIT scientists reverse some behavioral symptoms of rare neurodevelopmental disorder
April 22, 2019 - Scientists find new therapy target for drug-induced liver failure
April 22, 2019 - Opioid dose variability could lead to increased risk of overdose, study suggests
April 22, 2019 - Newly developed model predicts salmonella outbreaks several months in advance
April 22, 2019 - Deep-learning model better predicts survival outcomes for lung cancer
April 22, 2019 - One in Three U.S. Adults Aged 35 to 44 May Have Drinking Problem
April 22, 2019 - Why the measles virus is so contagious
April 22, 2019 - Magnet ‘Zap’ to the Brain Might Jumpstart Aging Memory
April 22, 2019 - Immune response to gut microbes may be early indicator of type 1 diabetes
April 22, 2019 - Destination Limbo: Health Suffers Among Asylum Seekers In Crowded Border Shelter
April 22, 2019 - Research shows how dopamine contributes to sex differences in worms
April 22, 2019 - Marijuana users weigh less compared to non-users
April 22, 2019 - Research uncovers critical RNA processing aberrations in ALS and FTD
April 22, 2019 - Many cancer patients use marijuana and prescription opioids, study reveals
April 22, 2019 - Frailty may up fracture risk in patients with type 2 diabetes
April 22, 2019 - Study provides new insight into how obesity, insulin resistance can affect cognition
April 22, 2019 - Study seeks to better understand the genetic causes for hypospadias
April 22, 2019 - FDA grants approval of first generic naloxone nasal spray to treat opioid overdose
April 22, 2019 - FDA authorizes marketing of first medical device to treat ADHD
New project launched to map out lung cancer immunology

New project launched to map out lung cancer immunology

image_pdfDownload PDFimage_print

A ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments will be created as part of a collaboration between Cancer Research UK, the Francis Crick Institute and Bristol-Myers Squibb, announced today (Friday).

The new £2.4 million research project called RUBICON – a rule book and immune atlas for combination therapy – will map out the immunology of lung cancer in detail.

The study will be led by Cancer Research UK’s chief clinician and Francis Crick Institute group leader, Professor Charles Swanton. He said: “Biological therapies, including immunotherapies are set to transform the way we treat patients and the RUBICON study will bring us a step closer to this vision.

“When we see patients with hard-to-treat cancers like lung, we struggle to keep up with the speed at which tumours evolve, become aggressive and resistant to treatment. Our research so far has uncovered many of cancer’s evolutionary secrets, opening opportunities for us to develop new and targeted biological therapies, and understand how they can be combined to maximum effect.

“By learning more about immune suppressive cell types – the molecules they express and how stable they are during disease evolution – we hope researchers can start to develop molecularly targeted immunotherapy combination strategies.”

The innovative project builds on Cancer Research UK’s strategic investment in lung cancer, enhancing our understanding of cancer evolution through tumour samples and data prospectively gathered and analysed as part of the TRACERx* and PEACE** studies, led by Professor Swanton and his team at the Cancer Research UK-Lung Cancer Centre of Excellence at UCL.

Multidisciplinary researchers at the Francis Crick Institute will use state of the art technologies, including deep learning and artificial intelligence tools, to analyse tumour samples and data from TRACERx and PEACE. This will allow them to map an atlas of immune cell activity across distinct tumour regions, and to understand how the incredibly complex tumour immune microenvironment evolves and develops over time.

Veronique Birault, head of translation at the Francis Crick Institute, said: “This project is a fantastic example of the industry and charity sectors working together to support world-class discovery science for the benefit of patients. The project wouldn’t be possible without Cancer Research UK’s significant investment in research, amplified by the complementary expertise of three different cancer labs collaborating at the Crick. This new funding will allow our scientists to map out the immune landscape around lung tumours to develop better combination therapies for patients.”

Dr Iain Foulkes, Cancer Research UK’s executive director of research and innovation, said: “We’re pleased to bring together these partners of industry and academia to advance this ambitious study. As we delve ever deeper into the tumour microenvironment, we can equip ourselves with the necessary knowledge to take the next steps toward truly personalised cancer treatments.

“Lung cancer is a disease for which there has been very little improvement in patient survival over the last 40 years. We look forward to seeing how new treatment combinations that arise from this study could make a real difference for these patients.”

Bristol-Myers Squibb will provide £2.4 million in funding for the RUBICON project.

“Bristol-Myers Squibb is proud to be part of this innovative research initiative. We look for first-class science everywhere and we know that continued progress in cancer can only happen through strong collaboration with scientists, academic researchers, clinicians and patients who participated in clinical trials,” said Tom Lynch, M.D., Executive Vice President and Chief Scientific Officer, Bristol-Myers Squibb.

“The UK has a strong heritage in cutting edge research and, through this RUBICON project, we believe further progress will be made for lung cancer patients across the world.”

Source:

https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2018-11-30-cancer-research-uk-the-francis-crick-institute-and-bristol-myers-squibb-join-forces-to-map-out-lung

Tagged with:

About author

Related Articles